MARLBOROUGH, Mass. -– GE Healthcare Life Sciences announced today that it will open a new 160,000 square-foot facility in Marlborough, Massachusetts, as the new headquarters for its US operations. A $21M investment in the long-term future of this key GE Healthcare growth business, it will establish a new site for more than 500 GE Healthcare […]
MADISON, WI — Promega Corporation announces its expansion into India with a 16th branch that serves the country’s scientific community with wide product availability, efficient delivery and technical support services. Promega Biotech India Private Ltd., a subsidiary of Promega Corporation, became fully operational on August 1, 2014. Located in New Delhi, India, the branch provides […]
CARLSBAD, Calif.– Life science researchers who want to expand their capabilities beyond traditional cell counting instruments can now do so with the Countess II FL, a next-generation, bench-top assay instrument with a modular design that broadens the number of applications on a single platform. “Our goal is to provide our customers with innovative tools that […]
BERGISCH GLADBACH, GERMANY -— Miltenyi Biotec announced today that it has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen Corporation, a global leader in lentiviral technology for cell and gene therapy applications. The acquisition further strengthens Miltenyi Biotec’s portfolio in cell and gene therapy. Assets obtained in the transaction include […]
BOULDER, CO –- ViroCyt, LLC, the leader in rapid virus quantification, announced today that its breakthrough Virus Counter instrument is being used by a group of laboratories to develop filovirus medical countermeasures. The Filovirus Animal Nonclinical Group or “FANG” is a US interdepartmental and interagency group established to support and facilitate the creation of vaccines […]
LA JOLLA, CA — Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced it has signed an agreement with Celgene Cellular Therapeutics (CCT) to license, develop, and co-promote Celgene’s proprietary placental cell population, PSC-100. HLI has the option to […]
ReproCELL Expects Synergy and Business Benefits through the Acquisitions of Reinnervate and BioServe
ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world’s first human iPS cell products in 2009 and with the world’s most advanced research and technology. Through the acquisitions of Reinnervate Limited […]
RESEARCH TRIANGLE PARK, N.C.– Triangle Research Labs, LLC and Biopredic International have completed an agreement for TRL to distribute the No-Spin HepaRG™ cells in North America. The No-Spin HepaRG™ represent an important improvement over the original cryopreserved HepaRG™ cells introduced three years ago for ADMET analyses. The HepaRG™ are renewable and reproducible hepatic cells derived […]
SOUTH SAN FRANCISCO, Calif.– In a paper published in Nature Biotechnology this week, UC San Francisco and Fluidigm Corporation (NASDAQ:FLDM) scientists have demonstrated that shallow single-cell mRNA sequencing (approximately 50,000 reads per cell) is sufficient for unbiased classification of cell identities. The study shows shallow sequencing of single cells provides enough data to distinguish cells […]
New York, NY — Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a growth equity investment in IsoPlexis Corporation. IsoPlexis has developed a break-through single cell immunoassay and related software that provides in-depth understanding of immune and cancer cells. The Company’s advanced cell […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
